Stockreport

AtaiBeckley reports 2025 results as it eyes Q2 start for Phase 3 depression trial [Yahoo! Finance]

AtaiBeckley Inc.  (ATAI) 
US:NASDAQ Investor Relations: ir.atai.net.cn
PDF AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) has reported its fourth quarter and full-year 2025 financial results, highlighting progress across several clinical programs t [Read more]